Osamu Matsui

Medicine · Health Sciences

73h-index23.5kcitations669works4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(222), Liver Disease Diagnosis and Treatment(149), Liver Disease and Transplantation(95), MRI in cancer diagnosis(65), Organ Transplantation Techniques and Outcomes(51)

Publications662 total

Effectiveness of music therapy combining life review and songwriting in patients with terminal cancer: a prospective study
2025Open Access
Super delayed phase imaging in gadoxetic acid-enhanced MRI: investigating factors contributing to improved liver contrast
European Radiology·2024· 1 citedOpen Access
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization
European Radiology·2023· 9 citedOpen Access
MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease
Radiology·2023· 2 cited
Fat fraction and R2 * values of various liver masses: Initial experience with 6-point Dixon method on a 3T MRI system
European Journal of Radiology Open·2023· 1 citedOpen Access
Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma
Radiology·2022· 40 cited
Transarterial chemoembolization for hepatocellular carcinoma with vascular invasion
British Journal of Radiology·2022· 8 citedOpen Access
Pathophysiology and Imaging Findings of Bile Duct Necrosis: A Rare but Serious Complication of Transarterial Therapy for Liver Tumors
Cancers·2020· 20 citedOpen Access
Intraarterial and intravenous contrast enhanced CT and MR imaging of multi-step hepatocarcinogenesis defining the early stage of hepatocellular carcinoma development
Hepatoma Research·2020· 4 citedOpen Access
Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas
Clinical Nuclear Medicine·2020· 12 cited
Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background
European Radiology·2020· 61 cited
Images of combined hepatocellular and cholangiocarcinoma
肝胆膵·2020
Peribiliary glands: development, dysfunction, related conditions and imaging findings
Abdominal Radiology·2019· 27 cited
Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach
Journal of Magnetic Resonance Imaging·2019· 34 citedOpen Access
Early detection of intrahepatic cholangiocarcinoma
Japanese Journal of Radiology·2019· 26 cited
Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features
European Radiology·2019· 15 cited
Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL)
Medical Oncology·2019· 20 citedOpen Access
Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma
Japanese Journal of Radiology·2019· 61 citedOpen Access
Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid–Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI
American Journal of Roentgenology·2018· 43 cited
Phase I/II Study of Radiofrequency Ablation for Painful Bone Metastases: Japan Interventional Radiology in Oncology Study Group 0208
CardioVascular and Interventional Radiology·2018· 19 cited
page 1 of 34Next →

Frequent Co-authors

Toshifumi Gabata(17), Masatoshi Kudo(12), Tsutomu Takashima(12), Namiki Izumi(11), Shiro Miyayama(10), M Kadoya(10), Norihiro Kokudo(9), Jun Yoshikawa(9), Yasuni Nakanuma(9), Michiie Sakamoto(8), Yoh Zen(8), Takafumi Ichida(8), Yonson Ku(8), Yutaka Matsuyama(8), Azusa Kitao(8), Osamu Nakashima(7), Masatoshi Makuuchi(6), Tatsuya Yamashita(6), Tadatoshi Takayama(6), Dai Inoue(6)